|
Name |
12-hydroxyl zygosporin G
|
| Molecular Formula | C30H37NO6 | |
| IUPAC Name* |
[16-benzyl-5-hydroxy-13-(hydroxymethyl)-5,7,14-trimethyl-6,18-dioxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9,12-trien-2-yl]acetate
|
|
| SMILES |
CC(=O)OC1C=CC(C)(O)C(=O)C(C)CC=CC2C=C(CO)C(C)C3C(Cc4ccccc4)NC(=O)C213
|
|
| InChI |
InChI=1S/C30H37NO6/c1-18-9-8-12-23-16-22(17-32)19(2)26-24(15-21-10-6-5-7-11-21)31-28(35)30(23,26)25(37-20(3)33)13-14-29(4,36)27(18)34/h5-8,10-14,16,18-19,23-26,32,36H,9,15,17H2,1-4H3,(H,31,35)/b12-8+,14-13+/t18-,19+,23-,24-,25+,26-,29+,30+/m0/s1
|
|
| InChIKey |
XTNPATOXKYCHLM-FNXBMICLSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 507.63 | ALogp: | 2.9 |
| HBD: | 3 | HBA: | 6 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 112.9 | Aromatic Rings: | 4 |
| Heavy Atoms: | 37 | QED Weighted: | 0.423 |
| Caco-2 Permeability: | -4.802 | MDCK Permeability: | 0.00003490 |
| Pgp-inhibitor: | 0.271 | Pgp-substrate: | 0.012 |
| Human Intestinal Absorption (HIA): | 0.19 | 20% Bioavailability (F20%): | 0.007 |
| 30% Bioavailability (F30%): | 0.005 |
| Blood-Brain-Barrier Penetration (BBB): | 0.942 | Plasma Protein Binding (PPB): | 90.87% |
| Volume Distribution (VD): | 1.63 | Fu: | 12.65% |
| CYP1A2-inhibitor: | 0.018 | CYP1A2-substrate: | 0.107 |
| CYP2C19-inhibitor: | 0.098 | CYP2C19-substrate: | 0.461 |
| CYP2C9-inhibitor: | 0.09 | CYP2C9-substrate: | 0.084 |
| CYP2D6-inhibitor: | 0.035 | CYP2D6-substrate: | 0.078 |
| CYP3A4-inhibitor: | 0.942 | CYP3A4-substrate: | 0.607 |
| Clearance (CL): | 2.45 | Half-life (T1/2): | 0.161 |
| hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.041 |
| Drug-inuced Liver Injury (DILI): | 0.974 | AMES Toxicity: | 0.021 |
| Rat Oral Acute Toxicity: | 0.867 | Maximum Recommended Daily Dose: | 0.566 |
| Skin Sensitization: | 0.031 | Carcinogencity: | 0.424 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
| Respiratory Toxicity: | 0.963 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004444 | ![]() |
0.861 | D01TSI | ![]() |
0.278 | ||
| ENC004026 | ![]() |
0.765 | D06CWH | ![]() |
0.272 | ||
| ENC004542 | ![]() |
0.703 | D0V3ZA | ![]() |
0.271 | ||
| ENC001922 | ![]() |
0.701 | D0SP3D | ![]() |
0.270 | ||
| ENC002202 | ![]() |
0.700 | D0E9KA | ![]() |
0.269 | ||
| ENC004463 | ![]() |
0.692 | D09NNH | ![]() |
0.264 | ||
| ENC005440 | ![]() |
0.689 | D0W7RJ | ![]() |
0.259 | ||
| ENC005439 | ![]() |
0.686 | D0A5LH | ![]() |
0.253 | ||
| ENC005441 | ![]() |
0.631 | D0D7KC | ![]() |
0.252 | ||
| ENC004468 | ![]() |
0.621 | D0TB8C | ![]() |
0.252 | ||